Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer

发表于 2026-7-3 16:27:52

期刊：Journal of Clinical Oncology

文献作者：Mirat Shah; Ting-Yu Chen; Gwynn Ison; Mallorie H. Fiero; Hui Zhang; Xin Gao; Marc Neilson; Kirsten B. Goldberg; Abhilasha Nair; Tiffany K. Ricks; William F. Pierce; Nicole Gormley; Marc R. Theoret; Shenghui Tang; Richard Pazdur; Paul G. Kluetz; Laleh Amiri-Kordestani

出版日期：2025-7-

DOI号：10.1200/jco-24-02834

下载链接：https://ascopubs.org/doi/pdfdirect/10.1200/JCO-24-02834

文献链接：https://doi.org/10.1200/jco-24-02834

当前文献来源于 American Society of Clinical Oncology (ASCO)。

备注信息：

发表于 2026-7-3 16:27:53

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[ASCO] Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ASCO] Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer 一键复制